Market knowledge and strategy consulting for Cardiothoracic and Vascular Surgeons
We are at the STS Annual Conference January 22nd – 24th
Come visit us at Booth 741
CG Health Partners achieves maximum compensation for cardiothoracic and vascular surgeons using
proprietary market valuation data combined with nonpareil practice and business model knowledge.
Creating Value Through Knowledge
In 2017, CG Health Partners will launch the first productivity and compensation study designed exclusively for cardiothoracic surgeons in the United States. Our goal is to provide relevant, timely and reliable information to cardiac and thoracic surgeons to define their true professional value.
As fewer cardiothoracic surgeons practice independently, compensation levels derive largely from historical national or regional market data. This market method of valuation has the advantage of convenience but significant limitations compared to more specific and rigorous methods of practice or physician valuation. Reasonably using market data for compensation decisions requires a valid study design with an adequately powered sample free from bias. We believe that most commercially available productivity and compensation reports fail their purpose for such errors. Specifically, we believe that low participation rates and sample bias artificially skew compensation and productivity data toward the lower end. More concerning, this phenomenon would tend to have a progressively downward pressure on earnings year after year.
Years of Experience
Total Contract Value
Cardiothoracic Surgeons Nationwide